A calprotectin stool test detects levels of calprotectin in stool. This protein indicates bowel inflammation. It can help diagnose and monitor conditions such as inflammatory bowel disease (IBD). A ...
July 22, 2010 — A new approach to the diagnosis of inflammatory bowel disease (IBD) — fecal calprotectin testing — is a useful tool for identifying patients who are most likely to need endoscopy for ...
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue of ...
New York, United States , June 22, 2024 (GLOBE NEWSWIRE) -- The Global Fecal Calprotectin Test Market Size is to Grow from USD 126.15 Million in 2023 to USD 366.15 Million by 2033, at a CAGR of 11.24% ...
A simple screening test identifies patients who are most likely to have inflammatory bowel disease and reduces the need for expensive, invasive and time consuming endoscopies, finds a new study. A ...
Of 575 patients enrolled in the study, 538 (94%, 248 male, 290 female) were included in the final analysis (Figure 1). Thirty-seven patients (6.4%) were excluded; 6 patients for incomplete endoscopy ...
The External Assessment Group did a systematic review of the evidence on cost effectiveness for faecal calprotectin testing and constructed a de novo economic model. The outcomes of interest for the ...
The global fecal calprotectin test market is on a trajectory of substantial growth, with projections estimating an increase from USD 68 million in 2023 to USD 160 million by 2031, reflecting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results